Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)

BACKGROUND: Esophageal cancer (EC) is one of the malignant tumors with a poor prognosis. The early stage of EC is asymptomatic, so identification of cancer biomarkers is important for early detection and clinical practice. METHODS: In this study, we compared the protein expression profiles in esopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yanping, Qi, Xiaoying, Yu, Cuicui, Yu, Shoujun, Zhang, Chao, Zhang, Yuan, Liu, Xiuxiu, Xu, Yuxue, Yang, Chunhua, Jiang, Wenguo, Tian, Geng, Li, Xuri, Bergquist, Jonas, Zhang, Jiandi, Wang, Lei, Mi, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449931/
https://www.ncbi.nlm.nih.gov/pubmed/30988666
http://dx.doi.org/10.1186/s12014-019-9232-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449931/
https://www.ncbi.nlm.nih.gov/pubmed/30988666
http://dx.doi.org/10.1186/s12014-019-9232-6

Ejemplares similares